查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1388186

静脉免疫球蛋白 (IVIG) 市场、份额、规模、趋势、行业分析报告：按给药途径、按成分、按应用、按最终用户、按分销渠道、按地区、细分市场预测，2023-2032 年

Intravenous immunoglobulin Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Intravenous, Subcutaneous); By Component; By Application; By End-user; By Distribution Channel; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris 市场研究的最新研究，到 2032 年，全球静脉注射免疫球蛋白 (IVIG) 市场规模预计将达到 241.3 亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

血浆分离技术和製造过程的进步使静脉注射免疫球蛋白 (IVIG) 产品更安全、更有效。 由于重组基因技术和纯化方法，免疫球蛋白製剂现已高度纯化和浓缩，减少了副作用的可能性并允许更精确的治疗。 这些进展提高了 IVIG 对原发性免疫缺陷性疾病和某些自体免疫疾病的疗效，为开发基于免疫球蛋白的新型疗法改善患者预后创造了机会。 正在进行的研究揭示了神经系统疾病的新治疗适应症，例如慢性发炎性脱髓鞘多发性神经炎、多灶性运动神经病变和重症肌无力。 扩大 IVIG 治疗的疾病范围将扩大基于免疫球蛋白的疗法的市场潜力，使它们造福更多人。

由于 COVID-19 大流行，全球静脉注射免疫球蛋白 (IVIG) 市场激增。 这项名为 "原发性和继发性免疫缺陷患者中的COVID-19：英国经验" 的研究于2020 年12 月进行，发现100 名患有症状性继发性免疫缺陷（SID）、原发性免疫缺陷（PID）和自体免疫缺陷等症状的患者疾病C1抑制剂缺乏，70%感染SARS-CoV-2病毒，其中59%住院，8%死亡。 这凸显了一个事实，即免疫功能低下的个体感染 COVID-19 的风险较高，预计将增加对静脉注射免疫球蛋白疗法来对抗这场流行病的需求。

静脉注射免疫球蛋白 (IVIG) 市场报告亮点

预计 IgG 细分市场在预测期内将是最大的细分市场。 IgG 已在临床试验中广泛研究，因此在医学领域中广泛使用和接受。 这些研究证明了 IgG 在治疗各种自体免疫疾病、神经系统疾病和其他免疫相关疾病方面的有效性和安全性。

2022年，免疫缺陷领域占据最大的市场份额。 免疫缺陷疾病分为两种：原发性（遗传性）和继发性（后天性）。 原发性免疫缺陷通常是遗传性的，从出生起就存在，而继发性免疫缺陷可能由于感染、药物和医疗程序等因素在以后的生活中出现。

到 2022 年，医院的份额将最高。 医院药房监测接受 IVIG 治疗的患者，与医疗保健专业人员合作追踪患者的进展，并向监管机构报告任何不良事件或反应。

2022年，全球市场将由北美地区主导。 这是因为北美拥有高度发展的医疗基础设施，支持该地区 IVIG 市场的成长。 由于癌症患者数量的不断增加以及百特国际等大公司的存在，越来越多的有效药物被引入市场。 此外，北美领先的製药公司正在研发、临床试验和行销策略方面进行大量投资，这正在推动 IVIG 市场的成长。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球静脉注射免疫球蛋白 (IVIG) 市场洞察

  • 静脉免疫球蛋白 (IVIG) - 产业概况
  • 静脉免疫球蛋白 (IVIG) 市场动态
    • 推动者和机会
      • 患有免疫缺陷疾病的人数不断增加
      • 采用基于免疫球蛋白的治疗
    • 抑制因素和挑战
      • 感染风险高，阻碍市场成长
  • 杵分析
  • 静脉免疫球蛋白 (IVIG) 产业趋势
  • COVID-19 感染的影响分析

第 5 章全球静脉免疫球蛋白 (IVIG) 市场（按组成部分）

  • 主要发现
  • 简介 IgG免疫球蛋白G
  • IgA
  • IgM
  • IgE
  • IgD

第 6 章全球静脉免疫球蛋白 (IVIG) 市场（依给药途径）

  • 主要发现
  • 简介
  • 静脉注射
  • 皮下

第七章全球静脉免疫球蛋白 (IVIG) 市场（依应用）

  • 主要发现
  • 简介
  • 低丙种球蛋白血症
  • 慢性发炎性脱髓鞘多发性神经病变 (CIDP)
  • 免疫缺乏疾病
  • 重症肌无力
  • 多灶性运动神经病变
  • 特发性血小板减少性紫斑症（ITP）
  • 发炎性肌肉病变
  • 特异性抗体缺乏
  • 吉兰-巴利症候群

第 8 章最终使用者全球静脉免疫球蛋白 (IVIG) 市场

  • 主要发现
  • 简介
  • 医院
  • 家庭医疗护理
  • 专科诊所

第 9 章全球静脉免疫球蛋白 (IVIG) 市场（依通路）

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局

第 10 章按地区划分的全球静脉免疫球蛋白 (IVIG) 市场

  • 主要发现
  • 简介
    • 2019-2032 年静脉免疫球蛋白 (IVIG) 市场评估（按地区）
  • 静脉注射免疫球蛋白 (IVIG) 市场 - 北美
    • 北美：静脉免疫球蛋白 (IVIG) 市场，按组成部分，2019-2032 年
    • 北美：静脉免疫球蛋白 (IVIG) 市场，按最终用户划分，2019-2032 年
    • 北美：静脉免疫球蛋白 (IVIG) 市场（按给药途径），2019-2032 年
    • 北美：静脉免疫球蛋白 (IVIG) 市场，按应用划分，2019-2032 年
    • 北美：静脉免疫球蛋白 (IVIG) 市场（依通路），2019-2032 年
    • 静脉免疫球蛋白 (IVIG) 市场 - 美国
    • 静脉免疫球蛋白 (IVIG) 市场 - 加拿大
  • 静脉免疫球蛋白 (IVIG) 市场 - 欧洲
    • 欧洲：静脉免疫球蛋白 (IVIG) 市场，按组成部分，2019-2032 年
    • 欧洲：静脉免疫球蛋白 (IVIG) 市场，按最终用户划分，2019-2032 年
    • 欧洲：静脉免疫球蛋白 (IVIG) 市场（按给药途径），2019-2032 年
    • 欧洲：静脉免疫球蛋白 (IVIG) 市场，按应用划分，2019-2032 年
    • 欧洲：静脉免疫球蛋白 (IVIG) 市场（依通路），2019-2032 年
    • 静脉免疫球蛋白 (IVIG) 市场 - 英国
    • 静脉免疫球蛋白 (IVIG) 市场 - 法国
    • 静脉免疫球蛋白 (IVIG) 市场 - 德国
    • 静脉免疫球蛋白 (IVIG) 市场 - 义大利
    • 静脉免疫球蛋白 (IVIG) 市场 - 西班牙
    • 静脉免疫球蛋白 (IVIG) 市场 - 荷兰
    • 静脉免疫球蛋白市场 - 俄罗斯
  • 静脉免疫球蛋白 (IVIG) 市场 - 亚太地区
    • 亚太地区：静脉免疫球蛋白 (IVIG) 市场，依组成部分，2019-2032 年
    • 亚太地区：静脉免疫球蛋白 (IVIG) 市场，按最终用户划分，2019-2032 年
    • 亚太地区：静脉免疫球蛋白 (IVIG) 市场（按给药途径），2019-2032 年
    • 亚太地区：静脉免疫球蛋白 (IVIG) 市场，依应用划分，2019-2032 年
    • 亚太地区：静脉免疫球蛋白 (IVIG) 市场（依通路），2019-2032 年
    • 静脉注射免疫球蛋白 (IVIG) 市场 - 中国
    • 静脉免疫球蛋白 (IVIG) 市场 - 印度
    • 静脉免疫球蛋白 (IVIG) 市场 - 日本
    • 静脉免疫球蛋白 (IVIG) 市场 - 马来西亚
    • 静脉免疫球蛋白 (IVIG) 市场 - 印度尼西亚
    • 静脉免疫球蛋白 (IVIG) 市场 - 韩国
  • 静脉免疫球蛋白 (IVIG) 市场 – 中东和非洲
    • 中东和非洲：静脉免疫球蛋白 (IVIG) 市场（按组成部分），2019-2032 年
    • 中东和非洲：静脉免疫球蛋白 (IVIG) 市场，按最终用户划分，2019-2032 年
    • 中东和非洲：静脉免疫球蛋白 (IVIG) 市场，按给药途径划分，2019-2032 年
    • 中东和非洲：静脉免疫球蛋白 (IVIG) 市场，按应用划分，2019-2032 年
    • 中东和非洲：静脉免疫球蛋白 (IVIG) 市场（按分销管道），2019-2032 年
    • 静脉免疫球蛋白 (IVIG) 市场 - 沙乌地阿拉伯
    • 静脉免疫球蛋白 (IVIG) 市场 - 阿联酋
    • 静脉免疫球蛋白 (IVIG) 市场 - 以色列
    • 静脉免疫球蛋白 (IVIG) 市场 - 南非
  • 静脉免疫球蛋白 (IVIG) 市场 - 拉丁美洲
    • 拉丁美洲：静脉免疫球蛋白 (IVIG) 市场，按组成部分，2019-2032 年
    • 拉丁美洲：静脉免疫球蛋白 (IVIG) 市场，按最终用户划分，2019-2032 年
    • 拉丁美洲：静脉免疫球蛋白 (IVIG) 市场，依给药途径划分，2019-2032 年
    • 拉丁美洲：静脉免疫球蛋白 (IVIG) 市场，按应用划分，2019-2032 年
    • 拉丁美洲：静脉免疫球蛋白 (IVIG) 市场（按分销管道），2019-2032 年
    • 静脉免疫球蛋白 (IVIG) 市场 - 墨西哥
    • 静脉免疫球蛋白 (IVIG) 市场 - 巴西
    • 静脉免疫球蛋白 (IVIG) 市场 - 阿根廷

第十一章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十二章公司简介

  • Baxter International Inc.
  • BDI Pharma Inc.
  • Biotest AG
  • China Biologics Products Inc.
  • CSL Behring
  • Grifols SA
  • Kedrion Biopharma
  • LFB Biotechnologies
  • Octapharma AG
Product Code: PM1297

The global intravenous immunoglobulin market size is expected to reach USD 24.13 billion by 2032, according to a new study by Polaris market research. The report "Intravenous immunoglobulin Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Intravenous, Subcutaneous); By Component; By Application; By End-user; By Distribution Channel; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Advancements in plasma fractionation techniques and manufacturing processes have made Intravenous Immunoglobulin (IVIG) products safer and more effective. Thanks to recombinant technologies and purification methods, immunoglobulin products are now highly refined and concentrated, which reduces the chance of adverse reactions and enables more precise therapies. These developments have improved the efficacy of IVIG for primary immune deficiencies, certain autoimmune disorders, and created opportunities for developing novel immunoglobulin-based treatments that can improve patient outcomes. Ongoing research has revealed new therapeutic indications for neurological conditions such as chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, and myasthenia gravis. The expansion of symptoms treated with IVIG provides a wider market potential for immunoglobulin-based therapies, which can benefit more people.

The global market for intravenous immunoglobulin saw a surge due to the COVID-19 pandemic. Research conducted in December 2020, named "COVID-19 in patients with primary and secondary immunodeficiency: The U.K. experience", found that 70% out of 100 people with symptomatic secondary immunodeficiency (SID), primary immunodeficiency (PID), autoinflammatory diseases, and C1 inhibitor deficiency were infected with the SARS-CoV-2 virus and 59% of them were admitted to hospitals, with 8% of them losing their lives. This highlights the fact that immunocompromised individuals are at a higher risk of getting COVID-19, leading to an expected increase in the demand for intravenous immunoglobulin therapy to combat the pandemic.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Intravenous immunoglobulin Market Report Highlights

During the forecast period, the IgG segment is expected to be the largest. IgG has been extensively researched in clinical trials, which has resulted in its widespread use and acceptance in the medical field. These studies have demonstrated IgG's efficacy and safety in treating various autoimmune disorders, neurological conditions, and other immune-related diseases.

The immunodeficiency diseases segment held the largest market share in 2022. Immunodeficiency diseases can be categorized into two types: primary (inherited) and secondary (acquired). Primary immunodeficiencies are typically genetic and present from birth, while secondary immunodeficiencies can develop later in life due to factors such as infections, medications, or medical treatments.

Hospitals accounted for the highest share in 2022. Hospital pharmacies monitor patients receiving IVIG therapy, collaborate with healthcare professionals to track patient progress, and report any adverse events or reactions to regulatory bodies.

In 2022, the global market was dominated by the North America region. This is because North America has a highly advanced healthcare infrastructure that supports the growth of the IVIG market in the region. With a rising number of cancer patients and the presence of key players such as Baxter International Inc., effective drugs are increasingly being introduced into the market. Furthermore, major pharmaceutical companies in North America invest heavily in research and development, clinical trials, and marketing strategies, which in turn drives the growth of the IVIG market.

The global key market players include: Baxter International Inc., BDI Pharma Inc., Biotest AG, China Biologics Products Inc., CSL Behring, Grifols SA, Kedrion Biopharma, LFB Biotechnologies, Octapharma AG

Polaris market research has segmented the Intravenous immunoglobulin market report based on component, route of administration, application, end-users, distribution channel and region:

Intravenous immunoglobulin, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • IGG
  • IGA
  • IGM
  • IGE
  • IGD

Intravenous immunoglobulin, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Intravenous
  • Subcutaneous

Intravenous immunoglobulin, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hypogammaglobulinemia
  • Chronic Inflammatory demyelinating polyneuropathy (CIDP)
  • Immunodeficiency diseases
  • Myasthenia Gravis
  • Multifocal motor neuropathy
  • Idiopathic thrombocytopenic purpura (ITP)
  • Inflammatory myopathies
  • Specific antibody deficiency
  • Guillain-Barre syndrome

Intravenous immunoglobulin, End-Users Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Homecare
  • Specialty Clinics

Intravenous immunoglobulin, Distribution channels Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies

Intravenous immunoglobulin, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Intravenous Immunoglobulin Market Insights

  • 4.1. Intravenous immunoglobulin - Industry Snapshot
  • 4.2. Intravenous immunoglobulin Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The number of people suffering from immunodeficiency disorders is on the rise.to drive the market growth
      • 4.2.1.2. Adoption of immunoglobulin-based therapies, drive the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High risk of transmission, hinder the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Intravenous immunoglobulin Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Intravenous immunoglobulin Market, by Component

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Intravenous Immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • 5.3. IGG
    • 5.3.1. Global Intravenous Immunoglobulin Market, by IGG, by Region, 2019-2032 (USD Billion)
  • 5.4. IGA
    • 5.4.1. Global Intravenous Immunoglobulin Market, by IGA, by Region, 2019-2032 (USD Billion)
  • 5.5. IGM
    • 5.5.1. Global Intravenous Immunoglobulin Market, by IGM, by Region, 2019-2032 (USD Billion)
  • 5.6. IGE
    • 5.6.1. Global Intravenous Immunoglobulin Market, by IGE, by Region, 2019-2032 (USD Billion)
  • 5.7. IGD
    • 5.7.1. Global Intravenous Immunoglobulin Market, by IGD, by Region, 2019-2032 (USD Billion)

6. Global Intravenous immunoglobulin Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Intravenous
    • 6.3.1. Global Intravenous immunoglobulin Market, by Intravenous, by Region, 2019-2032 (USD Billion)
  • 6.4. Subcutaneous
    • 6.4.1. Global Intravenous immunoglobulin Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)

7. Global Intravenous immunoglobulin Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Hypogammaglobulinemia
    • 7.3.1. Global Intravenous immunoglobulin Market, by Hypogammaglobulinemia, by Region, 2019-2032 (USD Billion)
  • 7.4. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
    • 7.4.1. Global Intravenous immunoglobulin Market, by Chronic Inflammatory demyelinating polyneuropathy (CIDP), by Region, 2019-2032 (USD Billion)
  • 7.5. Immunodeficiency diseases
    • 7.5.1. Global Intravenous immunoglobulin Market, by Immunodeficiency diseases, by Region, 2019-2032 (USD Billion)
  • 7.6. Myasthenia Gravis
    • 7.6.1. Global Intravenous immunoglobulin Market, by Myasthenia Gravis, by Region, 2019-2032 (USD Billion)
  • 7.7. Multifocal motor neuropathy
    • 7.7.1. Global Intravenous immunoglobulin Market, by Multifocal motor neuropathy, by Region, 2019-2032 (USD Billion)
  • 7.8. Idiopathic thrombocytopenic purpura (ITP)
    • 7.8.1. Global Intravenous immunoglobulin Market, by Idiopathic thrombocytopenic purpura (ITP), by Region, 2019-2032 (USD Billion)
  • 7.9. Inflammatory myopathies
    • 7.9.1. Global Intravenous immunoglobulin Market, by Inflammatory myopathies, by Region, 2019-2032 (USD Billion)
  • 7.10. Specific antibody deficiency
    • 7.10.1. Global Intravenous immunoglobulin Market, by Specific antibody deficiency, by Region, 2019-2032 (USD Billion)
  • 7.11. Guillain-Barre syndrome
    • 7.11.1. Global Intravenous immunoglobulin Market, by Guillain-Barre syndrome, by Region, 2019-2032 (USD Billion)

8. Global Intravenous immunoglobulin Market, by End Users

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Intravenous immunoglobulin Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 8.4. Homecare
    • 8.4.1. Global Intravenous immunoglobulin Market, by Homecare, by Region, 2019-2032 (USD Billion)
  • 8.5. Specialty Clinics
    • 8.5.1. Global Intravenous immunoglobulin Market, by Specialty Clinics, by Region, 2019-2032 (USD Billion)

9. Global Intravenous immunoglobulin Market, by Distribution Channel

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 9.3. Hospital Pharmacy
    • 9.3.1. Global Intravenous immunoglobulin Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.4. Retail Pharmacy
    • 9.4.1. Global Intravenous immunoglobulin Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.5. Online Pharmacies
    • 9.5.1. Global Intravenous immunoglobulin Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

10. Global Intravenous immunoglobulin Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Intravenous immunoglobulin Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Intravenous immunoglobulin Market - North America
    • 10.3.1. North America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.3.2. North America: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.3.3. North America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.4. North America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.3.5. North America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.6. Intravenous immunoglobulin Market - U.S.
      • 10.3.6.1. U.S.: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.7. Intravenous immunoglobulin Market - Canada
      • 10.3.7.1. Canada: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.4. Intravenous immunoglobulin Market - Europe
    • 10.4.1. Europe: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.6. Intravenous immunoglobulin Market - UK
      • 10.4.6.1. UK: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.7. Intravenous immunoglobulin Market - France
      • 10.4.7.1. France: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.8. Intravenous immunoglobulin Market - Germany
      • 10.4.8.1. Germany: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.9. Intravenous immunoglobulin Market - Italy
      • 10.4.9.1. Italy: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.10. Intravenous immunoglobulin Market - Spain
      • 10.4.10.1. Spain: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.11. Intravenous immunoglobulin Market - Netherlands
      • 10.4.11.1. Netherlands: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.12. Intravenous immunoglobulin Market - Russia
      • 10.4.12.1. Russia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.5. Intravenous immunoglobulin Market - Asia Pacific
    • 10.5.1. Asia Pacific: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.6. Intravenous immunoglobulin Market - China
      • 10.5.6.1. China: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.7. Intravenous immunoglobulin Market - India
      • 10.5.7.1. India: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.8. Intravenous immunoglobulin Market - Japan
      • 10.5.8.1. Japan: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.9. Intravenous immunoglobulin Market - Malaysia
      • 10.5.9.1. Malaysia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.10. Intravenous immunoglobulin Market - Indonesia
      • 10.5.10.1. Indonesia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.11. Intravenous immunoglobulin Market - South Korea
      • 10.5.11.1. South Korea: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.6. Intravenous immunoglobulin Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.6. Intravenous immunoglobulin Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.7. Intravenous immunoglobulin Market - UAE
      • 10.6.7.1. UAE: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.8. Intravenous immunoglobulin Market - Israel
      • 10.6.8.1. Israel: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.9. Intravenous immunoglobulin Market - South Africa
      • 10.6.9.1. South Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.7. Intravenous immunoglobulin Market - Latin America
    • 10.7.1. Latin America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.6. Intravenous immunoglobulin Market - Mexico
      • 10.7.6.1. Mexico: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.7. Intravenous immunoglobulin Market - Brazil
      • 10.7.7.1. Brazil: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.8. Intravenous immunoglobulin Market - Argentina
      • 10.7.8.1. Argentina: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Baxter International Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. BDI Pharma Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Biotest AG
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. China Biologics Products Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. CSL Behring
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Grifols SA
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Kedrion Biopharma
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. LFB Biotechnologies
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Octapharma AG
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development

List of Tables

  • Table 1 Global Intravenous immunoglobulin Market, by Component, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Intravenous immunoglobulin Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Intravenous immunoglobulin Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Intravenous immunoglobulin Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Intravenous immunoglobulin Market, by End Users, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 7 North America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 9 North America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 North America: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 11 U.S.: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 12 U.S.: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 U.S.: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 14 U.S.: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 15 U.S.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 16 Canada: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 17 Canada: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 18 Canada: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 19 Canada: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 Canada: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 21 Europe: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 22 Europe: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 23 Europe: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Europe: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Europe: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 26 Germany: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 27 Germany: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Germany: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Germany: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 30 Germany: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 31 France: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 32 France: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 France: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 34 France: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 France: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 36 UK: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 37 UK: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 38 UK: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 39 UK: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 UK: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 41 Italy: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 42 Italy: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 Italy: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 44 Italy: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 45 Italy: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 51 Spain: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 52 Spain: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 53 Spain: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 54 Spain: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Spain: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 56 Russia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 57 Russia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 Russia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Russia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 60 Russia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 66 China: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 67 China: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 China: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 69 China: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 China: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 71 Japan: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 72 Japan: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 Japan: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Japan: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 75 Japan: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 76 India: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 77 India: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 78 India: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 79 India: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 India: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 91 South Korea: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 92 South Korea: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 93 South Korea: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 94 South Korea: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 95 South Korea: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 96 Latin America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 97 Latin America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 98 Latin America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 99 Latin America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 100 Latin America: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 101 Brazil: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 102 Brazil: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 103 Brazil: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 104 Brazil: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 105 Brazil: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 106 Mexico: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 107 Mexico: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 Mexico: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 109 Mexico: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 110 Mexico: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 111 Argentina: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 112 Argentina: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 113 Argentina: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 114 Argentina: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 115 Argentina: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 121 UAE: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 122 UAE: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 123 UAE: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 124 UAE: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 125 UAE: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 131 South Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 132 South Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 133 South Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 134 South Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 135 South Africa: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 136 Israel: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 137 Israel: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 138 Israel: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 139 Israel: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 140 Israel: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Intravenous immunoglobulin Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Component
  • Figure 7. Global Intravenous immunoglobulin Market, by Component, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Intravenous immunoglobulin Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Intravenous immunoglobulin Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Intravenous immunoglobulin Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 14. Market by End Users
  • Figure 15. Global Intravenous immunoglobulin Market, by End Users, 2021 & 2030 (USD Billion)